SCHEME 3. Assembly of Fused Tetracyclic Compounds 16
Methyl 7-Methoxy-4-oxo-4,5-dihydropyrrolo[1,2-a]-quinoxaline-
2-carboxylate (9l). 1H NMR (400 MHz, DMSO-d6) δ 11.33 (s, 1H),
8.68 (d, J ) 1.4 Hz, 1H), 8.13 (d, J ) 10.1 Hz, 1H), 7.20, (d, J )
1.4 Hz, 1H), 6.80-6.72 (m, 2H), 3.78 (s, 3H), 3.75 (s, 3H); 13C
NMR (100 MHz, DMSO-d6) δ 164.16, 158.37, 155.38, 130.75,
124.18, 121.60, 118.62, 117.57, 116.63, 111.72, 109.72, 101.43,
56.01, 51.98; EI-MS m/z 272 (M+), 257, 241, 229; EI-HRMS calcd
for C14H12N2O4 (M+) 272.0797, found 272.0796.
2-Ethyl-8-methoxypyrrolo[1,2-a]quinoxalin-4(5H)-one (9m). 1H
NMR (400 MHz, DMSO-d6) δ 11.00 (s, 1H), 8.01 (d, J ) 0.9 Hz,
1H), 7.51 (d, J ) 2.8 Hz, 1H), 7.15 (d, J ) 9.2 Hz, 1H), 6.86-6.81
(m, 2H), 3.79 (s, 3H), 2.57 (q, J ) 7.3 Hz, 2H), 1.21 (t, J ) 7.3
Hz, 3H); 13C NMR (100 MHz, DMSO-d6) δ 155.65, 154.95, 130.55,
123.62, 122.47, 117.82, 116.06, 112.66, 111.23, 100.16, 56.35,
20.30, 15.52; EI-MS m/z 242 (M+), 227, 212, 199, 184; EI-HRMS
calcd for C14H14N2O2 (M+) 242.1055, found 242.1058.
1
2-Acetyl-7-ethylpyrrolo[1,2-a]quinoxalin-4(5H)-one (9n). H
room temperature and diluted with 150 mL of ethyl acetate, washed
with water, dried over Na2SO4, and concentrated in vacuo. The
residue was purified by column chromatography on silica gel
(eluting with 3:1 to 1:10 petroleum ether/ethyl acetate) to provide
the desired product.
NMR (400 MHz, DMSO-d6) δ 11.35 (s, 1H), 8.82 (d, J ) 1.8 Hz,
1H), 8.09 (d, J ) 7.8 Hz, 1H), 7.29 (d, J ) 1.8 Hz, 1H), 7.10-7.05
(m, 2H), 2.61 (q, J ) 7.3 Hz, 2H), 2.48 (s, 3H), 1.17 (t, J ) 7.3
Hz, 3H); 13C NMR (100 MHz, DMSO-d6) δ 193.54, 155.58, 143.25,
129.58, 128.10, 124.82, 123.04, 121.78, 120.69, 116.17, 115.98,
110.98, 28.29, 28.06, 15.90; EI-MS m/z 254 (M+), 239, 226, 211,
196, 183; EI-HRMS calcd for C15H14N2O2 (M+) 254.1055, found
254.1048.
Pyrrolo[1,2-a]quinoxalin-4(5H)-one (9a). 1H NMR (400 MHz,
DMSO-d6) δ 11.22 (s, 1H), 8.15 (dd, J ) 2.8, 1.4 Hz, 1H), 8.01
(d, J ) 7.8 Hz, 1H), 7.27-7.22 (m, 2H), 7.18-7.14 (m, 1H), 6.99
(dd, J ) 4.1, 1.4 Hz, 1H), 6.65 (dd, J ) 3.7, 2.8 Hz, 1H); 13C
NMR (100 MHz, DMSO-d6) δ 155.53, 129.04, 126.15, 123.78,
123.11, 123.07, 118.57, 116.99, 115.53, 113.25, 111.89; EI-MS m/z
184 (M+), 155, 129; EI-HRMS calcd for C11H8N2O (M+) 184.0637,
found 184.0642.
Methyl 2-Bromo-6-oxo-5,6-dihydropyrido[3,2-e]pyrrolo-[1,2-a]-
1
pyrazine-8-carboxylate (9o). H NMR (400 MHz, DMSO-d6) δ
11.63 (s, 1H), 8.25 (d, J ) 1.8 Hz, 1H), 7.60 (d, J ) 8.2 Hz, 1H),
7.53 (d, J ) 8.2 Hz, 1H), 7.24 (d, J ) 1.8 Hz, 1H), 3.79 (s, 3H);
13C NMR (100 MHz, DMSO-d6) δ 163.70, 154.65, 134.48, 131.30,
128.04, 127.13, 125.42, 125.26, 120.14, 119.84, 112.86, 52.26; EI-
MS m/z 323 (M+, 81Br), 321 (M+, 79Br), 292, 290, 262, 234; EI-
HRMS calcd for C12H8BrN3O3 (M+, 79Br) 320.9749, found
320.9747.
2-Ethylpyrrolo[1,2-a]quinoxalin-4(5H)-one (9b). 1H NMR (400
MHz, DMSO-d6) δ 11.15 (s, 1H), 7.96 (d, J ) 1.4 Hz, 1H), 7.93
(d, J ) 7.8 Hz, 1H), 7.27-7.11 (m, 3H), 6.85 (d, J ) 1.4 Hz, 1H),
2.58 (q, J ) 7.3 Hz, 2H), 1.20 (t, J ) 7.3 Hz, 3H); 13C NMR (100
MHz, DMSO-d6) δ 155.34, 130.61, 128.86, 125.68, 123.46, 123.02,
116.89, 115.86, 115.23, 111.27, 20.26, 15.55; EI-MS m/z 212 (M+),
197, 184, 168; EI-HRMS calcd for C13H12N2O (M+) 212.0950,
found 212.0959.
2-Acetylindolo[1,2-a]quinoxalin-6(5H)-one (16a). 1H NMR
(400 MHz, DMSO-d6) δ 11.83 (s, 1H), 8.75 (s, 1H), 8.33 (d, J )
8.7 Hz, 1H), 7.92 (d, J ) 8.3 Hz, 1H), 7.88 (d, J ) 8.2 Hz, 1H),
7.60 (t, J ) 8.7 Hz, 1H), 7.49 (s, 1H), 7.41-7.34 (m, 2H), 2.65 (s,
3H); 13C NMR (100 MHz, DMSO-d6) δ 196.84, 156.41, 134.35,
132.90, 131.93, 129.03, 128.75, 126.57, 125.75, 125.27, 123.73,
123.18, 117.01, 114.99, 114.59, 106.77, 27.15; EI-MS m/z 276
(M+), 261, 214, 199, 171; EI-HRMS calcd for C17H12N2O2 (M+)
276.0899, found 276.0887.
8-Methoxypyrrolo[1,2-a]quinoxalin-4(5H)-one (9f). 1H NMR
(400 MHz, DMSO-d6) δ 11.07 (s, 1H), 8.19 (dd, J ) 2.8, 1.4 Hz,
1H), 7.59 (d, J ) 2.3 Hz, 1H), 7.18 (d, J ) 8.7 Hz, 1H), 6.97 (dd,
J ) 3.7, 1.4 Hz, 1H), 6.88 (dd, J ) 8.7, 2.3 Hz, 1H), 6.64 (dd, J
) 3.7, 2.8 Hz, 1H), 3.80 (s, 3H); 13C NMR (100 MHz, DMSO-d6)
δ 155.67, 155.13, 123.93, 123.67, 122.66, 118.79, 117.92, 113.18,
112.97, 111.81, 100.64, 56.39; EI-MS m/z 214 (M+), 199, 171,
143; EI-HRMS calcd for C12H10N2O2 (M+) 214.0742, found
214.0746.
Acknowledgment. The authors are grateful to the Chinese
Academy of Sciences, National Natural Science Foundation of
China (grants 20321202 and 20572119) for their financial
support.
2-Acetyl-8-methylpyrrolo[1,2-a]quinoxalin-4(5H)-one (9k). 1H
NMR (400 MHz, DMSO-d6) δ 11.33 (s, 1H), 8.83 (d, J ) 1.4 Hz,
1H), 8.04 (s, 1H), 7.28 (d, J ) 1.4 Hz, 1H), 7.17-7.11 (m, 2H),
2.48 (s, 3H), 2.35 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ
193.51, 155.38, 132.89, 128.17, 128.07, 127.27, 125.06, 122.36,
121.85, 117.03, 116.25, 110.89, 28.02, 21.08; EI-MS m/z 240 (M+),
225, 197, 169, 112; EI-HRMS calcd for C14H12N2O2 (M+)
240.0899, found 240.0904.
Supporting Information Available: Analytical data of
1
compounds 9c-e, 9g-j, 9p, and 16b, and the copies of H
NMR and 13C NMR spectra for all new products. This material
JO8008098
5162 J. Org. Chem. Vol. 73, No. 13, 2008